Jane Street’s Arcadia Biosciences RKDA Stock Holding History

Jane Street’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.96K	Buy	+10,245	New	+$10.6K	﹤0.01%	11331
2023 Q1	–	Sell	-1,364	Closed	-$14.8K	–	9777
2022 Q4	$14.8K	Buy	1,364 +818	+150%	+$11.7K	﹤0.01%	8675
2022 Q3	$12K	Buy	+546	New	+$18.6K	﹤0.01%	9315
2022 Q2	–	Sell	-912	Closed	-$51K	–	10681
2022 Q1	$51K	Buy	912 +623	+216%	+$29.7K	﹤0.01%	9687
2021 Q4	$12K	Buy	+289	New	+$18.8K	﹤0.01%	9883
2021 Q3	–	Sell	-489	Closed	-$58K	–	10593
2021 Q2	$58K	Buy	+489	New	+$53.3K	﹤0.01%	9471
2019 Q4	–	Sell	-284	Closed	-$53K	–	5634
2019 Q3	$53K	Buy	+284	New	+$54.5K	﹤0.01%	4877

Other funds holding RKDA

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BWM

Bullock Wealth Management Bloomington, Indiana $231M AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Jane Street's RKDA Position: Q2 2026 in Review

Jane Street opened a new position in Arcadia Biosciences (RKDA) in Q2 2026: 10,245 shares worth $6.96K. The stake represents ﹤0.01% of the portfolio and ranks #11331 among its holdings. This is a return to the name: Jane Street previously reported a position in RKDA as recently as Q4 2022.

Jane Street first reported a position in RKDA in Q3 2019 and has held it in 7 quarters since. The position peaked at $58K in Q2 2021. 18 funds tracked by Wall St. Rank hold RKDA as of Q2 2026.

Jane Street held 10,245 shares of Arcadia Biosciences worth $6.96K as of Q2 2026.
Arcadia Biosciences was a new Jane Street position in Q2 2026.
Arcadia Biosciences made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11331 holding.
Jane Street first reported a position in Arcadia Biosciences in Q3 2019 and has held it in 7 quarters since.
Jane Street's Arcadia Biosciences position peaked at $58K in Q2 2021.
18 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.